Browsing ICR Divisions by author "Ratnakumaran, Ragu"
Now showing items 1-4 of 4
-
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
Alexander, JL; Ibraheim, H; Sheth, B; Little, J; Khan, MS; et al. (BMJ PUBLISHING GROUP, 2021-07-01)INTRODUCTION: Immune checkpoint inhibitors (CPIs) have changed the treatment landscape for many cancers, but also cause severe inflammatory side effects including enterocolitis. CPI-induced enterocolitis is treated empirically ... -
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Westley, RL; Biscombe, K; Dunlop, A; Mitchell, A; Oelfke, U; et al. (ELSEVIER SCIENCE INC, 2024-03-01)PURPOSE: Ultrahypofractionated radiation therapy (UHRT) is an effective treatment for localized prostate cancer with an acceptable toxicity profile; boosting the visible intraprostatic tumor has been shown to improve ... -
Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases.
Ratnakumaran, R; van As, N; Khoo, V; McDonald, F; Tait, D; et al. (ELSEVIER SCIENCE LONDON, 2023-05-01)AIMS: Stereotactic body radiotherapy (SBRT) is increasingly used to treat sacral metastases. We analysed our centre's local relapse rates and patterns of failure after sacral SBRT and assessed whether using the consensus ... -
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.
Ratnakumaran, R; Hinder, V; Brand, D; Staffurth, J; Hall, E; et al. (MDPI, 2023-02-17)Several studies have demonstrated the association between acute and late radiotherapy toxicity in prostate cancer using older radiotherapy techniques. However, whether this association is present with newer techniques such ...